A citation-based method for searching scientific literature

Douglas S Walsh, Chirapa Eamsila, Theerayuth Sasiprapha, Suebpong Sangkharomya, Pradith Khaewsathien, Panpaka Supakalin, Douglas B Tang, Phongsak Jarasrumgsichol, Chainarong Cherdchu, Michael D Edstein, Karl H Rieckmann, Thomas G Brewer. J Infect Dis 2004
Times Cited: 66







List of co-cited articles
642 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A new primaquine analogue, tafenoquine (WR 238605), for prophylaxis against Plasmodium falciparum malaria.
G D Shanks, A J Oloo, G M Aleman, C Ohrt, F W Klotz, D Braitman, J Horton, R Brueckner. Clin Infect Dis 2001
118
59

A randomized, double-blind, placebo-controlled, dose-ranging trial of tafenoquine for weekly prophylaxis against Plasmodium falciparum.
Braden R Hale, Seth Owusu-Agyei, David J Fryauff, Kwadwo A Koram, Martin Adjuik, Abraham R Oduro, W Roy Prescott, J Kevin Baird, Francis Nkrumah, Thomas L Ritchie,[...]. Clin Infect Dis 2003
62
56

Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse.
Douglas S Walsh, Polrat Wilairatana, Douglas B Tang, D Gray Heppner, Thomas G Brewer, Srivicha Krudsood, Udomsak Silachamroon, Weerapong Phumratanaprapin, Duangsuda Siriyanonda, Sornchai Looareesuwan. Clin Infect Dis 2004
80
43

Randomized, double-blind study of the safety, tolerability, and efficacy of tafenoquine versus mefloquine for malaria prophylaxis in nonimmune subjects.
Peter E Nasveld, Michael D Edstein, Mark Reid, Leonard Brennan, Ivor E Harris, Scott J Kitchener, Peter A Leggat, Philip Pickford, Caron Kerr, Colin Ohrt,[...]. Antimicrob Agents Chemother 2010
80
42

Malaria chemoprophylaxis with tafenoquine: a randomised study.
B Lell, J F Faucher, M A Missinou, S Borrmann, O Dangelmaier, J Horton, P G Kremsner. Lancet 2000
90
39

Randomized dose-ranging study of the safety and efficacy of WR 238605 (Tafenoquine) in the prevention of relapse of Plasmodium vivax malaria in Thailand.
D S Walsh, S Looareesuwan, P Wilairatana, D G Heppner, D B Tang, T G Brewer, W Chokejindachai, P Viriyavejakul, D E Kyle, W K Milhous,[...]. J Infect Dis 1999
76
34

First-time-in-humans safety and pharmacokinetics of WR 238605, a new antimalarial.
R P Brueckner, K C Lasseter, E T Lin, B G Schuster. Am J Trop Med Hyg 1998
99
33



Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study.
Alejandro Llanos-Cuentas, Marcus V Lacerda, Ronnatrai Rueangweerayut, Srivicha Krudsood, Sandeep K Gupta, Sanjay K Kochar, Preetam Arthur, Nuttagarn Chuenchom, Jörg J Möhrle, Stephan Duparc,[...]. Lancet 2014
184
25

Primaquine therapy for malaria.
J Kevin Baird, Stephen L Hoffman. Clin Infect Dis 2004
298
22

Plasma concentrations of tafenoquine, a new long-acting antimalarial agent, in thai soldiers receiving monthly prophylaxis.
Michael D Edstein, David A Kocisko, Douglas S Walsh, Chirapa Eamsila, Bruce G Charles, Karl H Rieckmann. Clin Infect Dis 2003
26
53

Population pharmacokinetics of the new antimalarial agent tafenoquine in Thai soldiers.
M D Edstein, D A Kocisko, T G Brewer, D S Walsh, C Eamsila, B G Charles. Br J Clin Pharmacol 2001
26
53

Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I.
David R Hill, J Kevin Baird, Monica E Parise, Linda S Lewis, Edward T Ryan, Alan J Magill. Am J Trop Med Hyg 2006
210
21

In vitro activity of tafenoquine against the asexual blood stages of Plasmodium falciparum isolates from Gabon, Senegal, and Djibouti.
Bruno Pradines, Modeste Mabika Mamfoumbi, Adama Tall, Cheikh Sokhna, Jean-Louis Koeck, Thierry Fusai, Joel Mosnier, Eric Czarnecki, André Spiegel, Jean-François Trape,[...]. Antimicrob Agents Chemother 2006
34
41

Prophylaxis of Plasmodium falciparum infection in a human challenge model with WR 238605, a new 8-aminoquinoline antimalarial.
R P Brueckner, T Coster, D L Wesche, M Shmuklarsky, B G Schuster. Antimicrob Agents Chemother 1998
66
21


The chemotherapy of rodent malaria. LI. Studies on a new 8-aminoquinoline, WR 238,605.
W Peters, B L Robinson, W K Milhous. Ann Trop Med Parasitol 1993
53
24

Tafenoquine: a promising new antimalarial agent.
Maryanne Crockett, Kevin C Kain. Expert Opin Investig Drugs 2007
55
21


Primaquine for prevention of malaria in travelers.
J Kevin Baird, David J Fryauff, Stephen L Hoffman. Clin Infect Dis 2003
84
16

Primaquine failure and cytochrome P-450 2D6 in Plasmodium vivax malaria.
Jason W Bennett, Brandon S Pybus, Anjali Yadava, Donna Tosh, Jason C Sousa, William F McCarthy, Gregory Deye, Victor Melendez, Christian F Ockenhouse. N Engl J Med 2013
189
16

Transmission-blocking activity of tafenoquine (WR-238605) and artelinic acid against naturally circulating strains of Plasmodium vivax in Thailand.
Narong Ponsa, Jetsumon Sattabongkot, Pattamaporn Kittayapong, Nantana Eikarat, Russell E Coleman. Am J Trop Med Hyg 2003
29
34

In vitro activity of tafenoquine alone and in combination with artemisinin against Plasmodium falciparum.
Michael Ramharter, Harald Noedl, Krongthong Thimasarn, Gerhard Wiedermann, Gunther Wernsdorfer, Walther H Wernsdorfer. Am J Trop Med Hyg 2002
31
32

Tafenoquine for the treatment of recurrent Plasmodium vivax malaria.
Scott Kitchener, Peter Nasveld, Michael D Edstein. Am J Trop Med Hyg 2007
21
47

The metabolism of primaquine to its active metabolite is dependent on CYP 2D6.
Brandon S Pybus, Sean R Marcsisin, Xiannu Jin, Gregory Deye, Jason C Sousa, Qigui Li, Diana Caridha, Qiang Zeng, Gregory A Reichard, Christian Ockenhouse,[...]. Malar J 2013
125
15

A randomized, double-blind, safety and tolerability study to assess the ophthalmic and renal effects of tafenoquine 200 mg weekly versus placebo for 6 months in healthy volunteers.
Kevin J Leary, Michael A Riel, Michael J Roy, Louis R Cantilena, Daoqin Bi, D Craig Brater, Corina van de Pol, Khadeeja Pruett, Caron Kerr, James M Veazey,[...]. Am J Trop Med Hyg 2009
21
47

Tafenoquine and NPC-1161B require CYP 2D metabolism for anti-malarial activity: implications for the 8-aminoquinoline class of anti-malarial compounds.
Sean R Marcsisin, Jason C Sousa, Gregory A Reichard, Diana Caridha, Qiang Zeng, Norma Roncal, Ronan McNulty, Julio Careagabarja, Richard J Sciotti, Jason W Bennett,[...]. Malar J 2014
63
15

8-Aminoquinolines active against blood stage Plasmodium falciparum in vitro inhibit hematin polymerization.
J L Vennerstrom, E O Nuzum, R E Miller, A Dorn, L Gerena, P A Dande, W Y Ellis, R G Ridley, W K Milhous. Antimicrob Agents Chemother 1999
61
14

Primaquine radical cure of Plasmodium vivax: a critical review of the literature.
George K John, Nicholas M Douglas, Lorenz von Seidlein, Francois Nosten, J Kevin Baird, Nicholas J White, Ric N Price. Malar J 2012
137
13

Pharmacokinetic interactions and safety evaluations of coadministered tafenoquine and chloroquine in healthy subjects.
Ann K Miller, Emma Harrell, Li Ye, Sharon Baptiste-Brown, Jőrg-Peter Kleim, Colin Ohrt, Stephan Duparc, Jörg J Möhrle, Alison Webster, Sandra Stinnett,[...]. Br J Clin Pharmacol 2013
34
26

Tafenoquine at therapeutic concentrations does not prolong Fridericia-corrected QT interval in healthy subjects.
Justin A Green, Apurva K Patel, Bela R Patel, Azra Hussaini, Emma J Harrell, Mirna J McDonald, Nick Carter, Khadeeja Mohamed, Stephan Duparc, Ann K Miller. J Clin Pharmacol 2014
26
34

Summary of anti-malarial prophylactic efficacy of tafenoquine from three placebo-controlled studies of residents of malaria-endemic countries.
Geoffrey S Dow, Jun Liu, Gina Lin, Brian Hetzell, Sarah Thieling, William F McCarthy, Douglas Tang, Bryan Smith. Malar J 2015
17
52

Hemolytic Potential of Tafenoquine in Female Volunteers Heterozygous for Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency (G6PD Mahidol Variant) versus G6PD-Normal Volunteers.
Ronnatrai Rueangweerayut, Germana Bancone, Emma J Harrell, Andrew P Beelen, Supornchai Kongpatanakul, Jörg J Möhrle, Vicki Rousell, Khadeeja Mohamed, Ammar Qureshi, Sushma Narayan,[...]. Am J Trop Med Hyg 2017
69
13

Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria.
Alejandro Llanos-Cuentas, Marcus V G Lacerda, Tran T Hien, Iván D Vélez, Chayadol Namaik-Larp, Cindy S Chu, Maria F Villegas, Fernando Val, Wuelton M Monteiro, Marcelo A M Brito,[...]. N Engl J Med 2019
109
13


Population pharmacokinetics of tafenoquine during malaria prophylaxis in healthy subjects.
Bruce G Charles, Ann K Miller, Peter E Nasveld, Mark G Reid, Ivor E Harris, Michael D Edstein. Antimicrob Agents Chemother 2007
20
40

Primaquine in vivax malaria: an update and review on management issues.
Deepika Fernando, Chaturaka Rodrigo, Senaka Rajapakse. Malar J 2011
103
12

Radical curative efficacy of tafenoquine combination regimens in Plasmodium cynomolgi-infected Rhesus monkeys (Macaca mulatta).
Geoffrey S Dow, Montip Gettayacamin, Pranee Hansukjariya, Rawiwan Imerbsin, Srawuth Komcharoen, Jetsumon Sattabongkot, Dennis Kyle, Wilbur Milhous, Simon Cozens, David Kenworthy,[...]. Malar J 2011
49
16

Tafenoquine treatment of Plasmodium vivax malaria: suggestive evidence that CYP2D6 reduced metabolism is not associated with relapse in the Phase 2b DETECTIVE trial.
Pamela L St Jean, Zhengyu Xue, Nick Carter, Gavin C K W Koh, Stephan Duparc, Maxine Taylor, Claire Beaumont, Alejandro Llanos-Cuentas, Ronnatrai Rueangweerayut, Srivicha Krudsood,[...]. Malar J 2016
58
13

Enzymatic deficiency in primaquine-sensitive erythrocytes.
A S ALVING, P E CARSON, C L FLANAGAN, C E ICKES. Science 1956
710
10

Delayed onset of malaria--implications for chemoprophylaxis in travelers.
Eli Schwartz, Monica Parise, Phyllis Kozarsky, Martin Cetron. N Engl J Med 2003
117
10

Treatment of acute vivax malaria with tafenoquine.
Peter Nasveld, Scott Kitchener. Trans R Soc Trop Med Hyg 2005
56
12

Effectiveness of antimalarial drugs.
J Kevin Baird. N Engl J Med 2005
214
10

Antimalarial drug toxicity: a review.
W Robert J Taylor, Nicholas J White. Drug Saf 2004
299
10

Vivax malaria: neglected and not benign.
Ric N Price, Emiliana Tjitra, Carlos A Guerra, Shunmay Yeung, Nicholas J White, Nicholas M Anstey. Am J Trop Med Hyg 2007
583
10


Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study.
D Overbosch, H Schilthuis, U Bienzle, R H Behrens, K C Kain, P D Clarke, S Toovey, J Knobloch, H D Nothdurft, D Shaw,[...]. Clin Infect Dis 2001
173
9

Toxicology of the 8-aminoquinolines and genetic factors associated with their toxicity in man.
P E Carson, R Hohl, M V Nora, G W Parkhurst, T Ahmad, S Scanlan, H Frischer. Bull World Health Organ 1981
46
13



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.